APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Oral Anti-HBV Drugs

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Oral Anti-HBV Drugs Industry Growth and Trends Forecast to 2032

Report ID 174019530128 December 2025124 pages

Choose your research edition.

Industry ResearchOral Anti-HBV Drugs Industry Research Report 2026143 pages · $2,950 USDIndustry Growth & TrendsGlobal Oral Anti-HBV Drugs Industry Growth and Trends Forecast to 2032124 pages · $3,450 USDMarket StructureGlobal Oral Anti-HBV Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Oral Anti-HBV Drugs Market Outlook and Growth Opportunities 2026211 pages · $4,250 USDMarket Analysis & ForecastGlobal Oral Anti-HBV Drugs Market Analysis and Forecast 2026-2032219 pages · $4,950 USD

Market perspective

The global Oral Anti-HBV Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Oral Anti-HBV Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Oral Anti-HBV Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Oral Anti-HBV Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Oral Anti-HBV Drugs include Zhongfu Pharmaceutical, Chia Tai Tianqing Pharmaceutical, Easton Biopharmaceuticals, YaoPharma, Tianjin Yaowu Academe Pharmaceutical Industry, Sichuan Kelun Pharmaceutical, Shanghai Desano Pharmaceutical, Qianjin Pharmaceutical and Qilu Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Oral Anti-HBV Drugs market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Oral Anti-HBV Drugs market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Oral Anti-HBV Drugs market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Oral Anti-HBV Drugs.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Oral Anti-HBV Drugs market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Oral Anti-HBV Drugs Market by Company

Zhongfu Pharmaceutical

Chia Tai Tianqing Pharmaceutical

Easton Biopharmaceuticals

YaoPharma

Tianjin Yaowu Academe Pharmaceutical Industry

Sichuan Kelun Pharmaceutical

Shanghai Desano Pharmaceutical

Qianjin Pharmaceutical

Qilu Pharmaceutical

Jiangxi Qingfeng Pharmaceutical

Fujian Cosunter pharmaceutical

Chengdu Brilliant Pharmaceutical

Cisen Pharmaceutical

Beijing SL Pharmaceutical

Beijing Baiao Pharmaceutical

Anhui Biochem

Viatris

Towa Pharmaceutical

Teva

Sigmapharm Laboratories

Sandoz Pharmaceuticals

GSK

Gilead Sciences

Camber Pharmaceuticals

Bristol Myers Squibb

Apotex

Oral Anti-HBV Drugs Segment by Type

Adefovir

Entecavir

Lamivudine

Telbivudine

Tenofovir

Other

Oral Anti-HBV Drugs Segment by Application

Hospital and Clinic

Pharmacy

Other

Oral Anti-HBV Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oral Anti-HBV Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Oral Anti-HBV Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oral Anti-HBV Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Oral Anti-HBV Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Oral Anti-HBV Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Adefovir Table 2. Major Company of Entecavir Table 3. Major Company of Lamivudine Table 4. Major Company of Telbivudine Table 5. Major Company of Tenofovir Table 6. Major Company of Other Table 7. Global Oral Anti-HBV Drugs Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 8. Global Oral Anti-HBV Drugs Sales by Type (2021-2026) & (K Units) Table 9. Global Oral Anti-HBV Drugs Sales Market Share in Volume by Type (2021-2026) Table 10. Global Oral Anti-HBV Drugs Sales by Type (2021-2026) & (US$ Million) Table 11. Global Oral Anti-HBV Drugs Sales Market Share in Value by Type (2021-2026) Table 12. Global Oral Anti-HBV Drugs Price by Type (2021-2026) & (US$/Unit) Table 13. Global Oral Anti-HBV Drugs Sales by Type (2027-2032) & (K Units) Table 14. Global Oral Anti-HBV Drugs Sales Market Share in Volume by Type (2027-2032) Table 15. Global Oral Anti-HBV Drugs Sales by Type (2027-2032) & (US$ Million) Table 16. Global Oral Anti-HBV Drugs Sales Market Share in Value by Type (2027-2032) Table 17. Global Oral Anti-HBV Drugs Price by Type (2027-2032) & (US$/Unit) Table 18. North America Oral Anti-HBV Drugs Sales by Type (2021-2026) & (K Units) Table 19. North America Oral Anti-HBV Drugs Sales by Type (2021-2026) & (US$ Million) Table 20. Europe Oral Anti-HBV Drugs Sales by Type (2021-2026) & (K Units) Table 21. Europe Oral Anti-HBV Drugs Sales by Type (2021-2026) & (US$ Million) Table 22. Asia-Pacific Oral Anti-HBV Drugs Sales by Type (2021-2026) & (K Units) Table 23. Asia-Pacific Oral Anti-HBV Drugs Sales by Type (2021-2026) & (US$ Million) Table 24. Latin America Oral Anti-HBV Drugs Sales by Type (2021-2026) & (K Units) Table 25. Latin America Oral Anti-HBV Drugs Sales by Type (2021-2026) & (US$ Million) Table 26. Middle East and Africa Oral Anti-HBV Drugs Sales by Type (2021-2026) & (K Units) Table 27. Middle East and Africa Oral Anti-HBV Drugs Sales by Type (2021-2026) & (US$ Million) Table 28. Oral Anti-HBV Drugs Industry Trends Table 29. Oral Anti-HBV Drugs Industry Drivers Table 30. Oral Anti-HBV Drugs Industry Opportunities and Challenges Table 31. Oral Anti-HBV Drugs Industry Restraints Table 32. Global Oral Anti-HBV Drugs Sales Revenue by Company (US$ Million) & (2021-2026) Table 33. Global Oral Anti-HBV Drugs Revenue Market Share by Company (2021-2026) Table 34. Global Oral Anti-HBV Drugs Sales by Company (2021-2026) & (K Units) Table 35. Global Oral Anti-HBV Drugs Sales Share by Company (2021-2026) Table 36. Global Oral Anti-HBV Drugs Market Price by Company (2021-2026) & (US$/Unit) Table 37. Global Oral Anti-HBV Drugs Industry Company Ranking, 2024 VS 2025 VS 2026 Table 38. Global Oral Anti-HBV Drugs Major Company Production Sites and Headquarters Table 39. Global Oral Anti-HBV Drugs Company, Product Type & Application Table 40. Global Oral Anti-HBV Drugs Company Establishment Date Table 41. Global Company Market Concentration Ratio (CR5 and HHI) Table 42. Global Oral Anti-HBV Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 43. Global Oral Anti-HBV Drugs Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 44. Global Oral Anti-HBV Drugs Sales by Region (2021-2026) & (K Units) Table 45. Global Oral Anti-HBV Drugs Sales Market Share in Volume by Region (2021-2026) Table 46. Global Oral Anti-HBV Drugs Sales by Region (2021-2026) & (US$ Million) Table 47. Global Oral Anti-HBV Drugs Sales Market Share in Value by Region (2021-2026) Table 48. Global Oral Anti-HBV Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 49. Global Oral Anti-HBV Drugs Sales by Region (2027-2032) & (K Units) Table 50. Global Oral Anti-HBV Drugs Sales Market Share in Volume by Region (2027-2032) Table 51. Global Oral Anti-HBV Drugs Sales by Region (2027-2032) & (US$ Million) Table 52. Global Oral Anti-HBV Drugs Sales Market Share in Value by Region (2027-2032) Table 53. Global Oral Anti-HBV Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 54. Global Oral Anti-HBV Drugs Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 55. Global Oral Anti-HBV Drugs Sales by Application (2021-2026) & (K Units) Table 56. Global Oral Anti-HBV Drugs Sales Market Share in Volume by Application (2021-2026) Table 57. Global Oral Anti-HBV Drugs Sales by Application (2021-2026) & (US$ Million) Table 58. Global Oral Anti-HBV Drugs Sales Market Share in Value by Application (2021-2026) Table 59. Global Oral Anti-HBV Drugs Price by Application (2021-2026) & (US$/Unit) Table 60. Global Oral Anti-HBV Drugs Sales by Application (2027-2032) & (K Units) Table 61. Global Oral Anti-HBV Drugs Sales Market Share in Volume by Application (2027-2032) Table 62. Global Oral Anti-HBV Drugs Sales by Application (2027-2032) & (US$ Million) Table 63. Global Oral Anti-HBV Drugs Sales Market Share in Value by Application (2027-2032) Table 64. Global Oral Anti-HBV Drugs Price by Application (2027-2032) & (US$/Unit) Table 65. North America Oral Anti-HBV Drugs Sales by Application (2021-2026) & (K Units) Table 66. North America Oral Anti-HBV Drugs Sales by Application (2021-2026) & (US$ Million) Table 67. Europe Oral Anti-HBV Drugs Sales by Application (2021-2026) & (K Units) Table 68. Europe Oral Anti-HBV Drugs Sales by Application (2021-2026) & (US$ Million) Table 69. Asia-Pacific Oral Anti-HBV Drugs Sales by Application (2021-2026) & (K Units) Table 70. Asia-Pacific Oral Anti-HBV Drugs Sales by Application (2021-2026) & (US$ Million) Table 71. Latin America Oral Anti-HBV Drugs Sales by Application (2021-2026) & (K Units) Table 72. Latin America Oral Anti-HBV Drugs Sales by Application (2021-2026) & (US$ Million) Table 73. Middle East and Africa Oral Anti-HBV Drugs Sales by Application (2021-2026) & (K Units) Table 74. Middle East and Africa Oral Anti-HBV Drugs Sales by Application (2021-2026) & (US$ Million) Table 75. Zhongfu Pharmaceutical Company Information Table 76. Zhongfu Pharmaceutical Business Overview Table 77. Zhongfu Pharmaceutical Oral Anti-HBV Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 78. Zhongfu Pharmaceutical Oral Anti-HBV Drugs Product Portfolio Table 79. Zhongfu Pharmaceutical Recent Development Table 80. Chia Tai Tianqing Pharmaceutical Company Information Table 81. Chia Tai Tianqing Pharmaceutical Business Overview Table 82. Chia Tai Tianqing Pharmaceutical Oral Anti-HBV Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 83. Chia Tai Tianqing Pharmaceutical Oral Anti-HBV Drugs Product Portfolio Table 84. Chia Tai Tianqing Pharmaceutical Recent Development Table 85. Easton Biopharmaceuticals Company Information Table 86. Easton Biopharmaceuticals Business Overview Table 87. Easton Biopharmaceuticals Oral Anti-HBV Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 88. Easton Biopharmaceuticals Oral Anti-HBV Drugs Product Portfolio Table 89. Easton Biopharmaceuticals Recent Development Table 90. YaoPharma Company Information Table 91. YaoPharma Business Overview Table 92. YaoPharma Oral Anti-HBV Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. YaoPharma Oral Anti-HBV Drugs Product Portfolio Table 94. YaoPharma Recent Development Table 95. Tianjin Yaowu Academe Pharmaceutical Industry Company Information Table 96. Tianjin Yaowu Academe Pharmaceutical Industry Business Overview Table 97. Tianjin Yaowu Academe Pharmaceutical Industry Oral Anti-HBV Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 98. Tianjin Yaowu Academe Pharmaceutical Industry Oral Anti-HBV Drugs Product Portfolio Table 99. Tianjin Yaowu Academe Pharmaceutical Industry Recent Development Table 100. Sichuan Kelun Pharmaceutical Company Information Table 101. Sichuan Kelun Pharmaceutical Business Overview Table 102. Sichuan Kelun Pharmaceutical Oral Anti-HBV Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 103. Sichuan Kelun Pharmaceutical Oral Anti-HBV Drugs Product Portfolio Table 104. Sichuan Kelun Pharmaceutical Recent Development Table 105. Shanghai Desano Pharmaceutical Company Information Table 106. Shanghai Desano Pharmaceutical Business Overview Table 107. Shanghai Desano Pharmaceutical Oral Anti-HBV Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 108. Shanghai Desano Pharmaceutical Oral Anti-HBV Drugs Product Portfolio Table 109. Shanghai Desano Pharmaceutical Recent Development Table 110. Qianjin Pharmaceutical Company Information Table 111. Qianjin Pharmaceutical Business Overview Table 112. Qianjin Pharmaceutical Oral Anti-HBV Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 113. Qianjin Pharmaceutical Oral Anti-HBV Drugs Product Portfolio Table 114. Qianjin Pharmaceutical Recent Development Table 115. Qilu Pharmaceutical Company Information Table 116. Qilu Pharmaceutical Business Overview Table 117. Qilu Pharmaceutical Oral Anti-HBV Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 118. Qilu Pharmaceutical Oral Anti-HBV Drugs Product Portfolio Table 119. Qilu Pharmaceutical Recent Development Table 120. Jiangxi Qingfeng Pharmaceutical Company Information Table 121. Jiangxi Qingfeng Pharmaceutical Business Overview Table 122. Jiangxi Qingfeng Pharmaceutical Oral Anti-HBV Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 123. Jiangxi Qingfeng Pharmaceutical Oral Anti-HBV Drugs Product Portfolio Table 124. Jiangxi Qingfeng Pharmaceutical Recent Development Table 125. Fujian Cosunter pharmaceutical Company Information Table 126. Fujian Cosunter pharmaceutical Business Overview Table 127. Fujian Cosunter pharmaceutical Oral Anti-HBV Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 128. Fujian Cosunter pharmaceutical Oral Anti-HBV Drugs Product Portfolio Table 129. Fujian Cosunter pharmaceutical Recent Development Table 130. Chengdu Brilliant Pharmaceutical Company Information Table 131. Chengdu Brilliant Pharmaceutical Business Overview Table 132. Chengdu Brilliant Pharmaceutical Oral Anti-HBV Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 133. Chengdu Brilliant Pharmaceutical Oral Anti-HBV Drugs Product Portfolio Table 134. Chengdu Brilliant Pharmaceutical Recent Development Table 135. Cisen Pharmaceutical Company Information Table 136. Cisen Pharmaceutical Business Overview Table 137. Cisen Pharmaceutical Oral Anti-HBV Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 138. Cisen Pharmaceutical Oral Anti-HBV Drugs Product Portfolio Table 139. Cisen Pharmaceutical Recent Development Table 140. Beijing SL Pharmaceutical Company Information Table 141. Beijing SL Pharmaceutical Business Overview Table 142. Beijing SL Pharmaceutical Oral Anti-HBV Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 143. Beijing SL Pharmaceutical Oral Anti-HBV Drugs Product Portfolio Table 144. Beijing SL Pharmaceutical Recent Development Table 145. Beijing Baiao Pharmaceutical Company Information Table 146. Beijing Baiao Pharmaceutical Business Overview Table 147. Beijing Baiao Pharmaceutical Oral Anti-HBV Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 148. Beijing Baiao Pharmaceutical Oral Anti-HBV Drugs Product Portfolio Table 149. Beijing Baiao Pharmaceutical Recent Development Table 150. Anhui Biochem Company Information Table 151. Anhui Biochem Business Overview Table 152. Anhui Biochem Oral Anti-HBV Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 153. Anhui Biochem Oral Anti-HBV Drugs Product Portfolio Table 154. Anhui Biochem Recent Development Table 155. Viatris Company Information Table 156. Viatris Business Overview Table 157. Viatris Oral Anti-HBV Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 158. Viatris Oral Anti-HBV Drugs Product Portfolio Table 159. Viatris Recent Development Table 160. Towa Pharmaceutical Company Information Table 161. Towa Pharmaceutical Business Overview Table 162. Towa Pharmaceutical Oral Anti-HBV Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 163. Towa Pharmaceutical Oral Anti-HBV Drugs Product Portfolio Table 164. Towa Pharmaceutical Recent Development Table 165. Teva Company Information Table 166. Teva Business Overview Table 167. Teva Oral Anti-HBV Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 168. Teva Oral Anti-HBV Drugs Product Portfolio Table 169. Teva Recent Development Table 170. Sigmapharm Laboratories Company Information Table 171. Sigmapharm Laboratories Business Overview Table 172. Sigmapharm Laboratories Oral Anti-HBV Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 173. Sigmapharm Laboratories Oral Anti-HBV Drugs Product Portfolio Table 174. Sigmapharm Laboratories Recent Development Table 175. Sandoz Pharmaceuticals Company Information Table 176. Sandoz Pharmaceuticals Business Overview Table 177. Sandoz Pharmaceuticals Oral Anti-HBV Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 178. Sandoz Pharmaceuticals Oral Anti-HBV Drugs Product Portfolio Table 179. Sandoz Pharmaceuticals Recent Development Table 180. GSK Company Information Table 181. GSK Business Overview Table 182. GSK Oral Anti-HBV Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 183. GSK Oral Anti-HBV Drugs Product Portfolio Table 184. GSK Recent Development Table 185. Gilead Sciences Company Information Table 186. Gilead Sciences Business Overview Table 187. Gilead Sciences Oral Anti-HBV Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 188. Gilead Sciences Oral Anti-HBV Drugs Product Portfolio Table 189. Gilead Sciences Recent Development Table 190. Camber Pharmaceuticals Company Information Table 191. Camber Pharmaceuticals Business Overview Table 192. Camber Pharmaceuticals Oral Anti-HBV Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 193. Camber Pharmaceuticals Oral Anti-HBV Drugs Product Portfolio Table 194. Camber Pharmaceuticals Recent Development Table 195. Bristol Myers Squibb Company Information Table 196. Bristol Myers Squibb Business Overview Table 197. Bristol Myers Squibb Oral Anti-HBV Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 198. Bristol Myers Squibb Oral Anti-HBV Drugs Product Portfolio Table 199. Bristol Myers Squibb Recent Development Table 200. Apotex Company Information Table 201. Apotex Business Overview Table 202. Apotex Oral Anti-HBV Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 203. Apotex Oral Anti-HBV Drugs Product Portfolio Table 204. Apotex Recent Development Table 205. North America Oral Anti-HBV Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 206. North America Oral Anti-HBV Drugs Sales by Country (2021-2026) & (K Units) Table 207. North America Oral Anti-HBV Drugs Sales Market Share by Country (2021-2026) Table 208. North America Oral Anti-HBV Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 209. North America Oral Anti-HBV Drugs Sales Market Share Forecast by Country (2027-2032) Table 210. North America Oral Anti-HBV Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 211. North America Oral Anti-HBV Drugs Market Size by Country (2021-2026) & (US$ Million) Table 212. North America Oral Anti-HBV Drugs Market Share by Country (2021-2026) Table 213. North America Oral Anti-HBV Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 214. North America Oral Anti-HBV Drugs Market Share Forecast by Country (2027-2032) Table 215. Europe Oral Anti-HBV Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 216. Europe Oral Anti-HBV Drugs Sales by Country (2021-2026) & (K Units) Table 217. Europe Oral Anti-HBV Drugs Sales Market Share by Country (2021-2026) Table 218. Europe Oral Anti-HBV Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 219. Europe Oral Anti-HBV Drugs Sales Market Share Forecast by Country (2027-2032) Table 220. Europe Oral Anti-HBV Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 221. Europe Oral Anti-HBV Drugs Market Size by Country (2021-2026) & (US$ Million) Table 222. Europe Oral Anti-HBV Drugs Market Share by Country (2021-2026) Table 223. Europe Oral Anti-HBV Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 224. Europe Oral Anti-HBV Drugs Market Share Forecast by Country (2027-2032) Table 225. Asia-Pacific Oral Anti-HBV Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 226. Asia-Pacific Oral Anti-HBV Drugs Sales by Country (2021-2026) & (K Units) Table 227. Asia-Pacific Oral Anti-HBV Drugs Sales Market Share by Country (2021-2026) Table 228. Asia-Pacific Oral Anti-HBV Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 229. Asia-Pacific Oral Anti-HBV Drugs Sales Market Share Forecast by Country (2027-2032) Table 230. Asia-Pacific Oral Anti-HBV Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 231. Asia-Pacific Oral Anti-HBV Drugs Market Size by Country (2021-2026) & (US$ Million) Table 232. Asia-Pacific Oral Anti-HBV Drugs Market Share by Country (2021-2026) Table 233. Asia-Pacific Oral Anti-HBV Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 234. Asia-Pacific Oral Anti-HBV Drugs Market Share Forecast by Country (2027-2032) Table 235. Latin America Oral Anti-HBV Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 236. Latin America Oral Anti-HBV Drugs Sales by Country (2021-2026) & (K Units) Table 237. Latin America Oral Anti-HBV Drugs Sales Market Share by Country (2021-2026) Table 238. Latin America Oral Anti-HBV Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 239. Latin America Oral Anti-HBV Drugs Sales Market Share Forecast by Country (2027-2032) Table 240. Latin America Oral Anti-HBV Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 241. Latin America Oral Anti-HBV Drugs Market Size by Country (2021-2026) & (US$ Million) Table 242. Latin America Oral Anti-HBV Drugs Market Share by Country (2021-2026) Table 243. Latin America Oral Anti-HBV Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 244. Latin America Oral Anti-HBV Drugs Market Share Forecast by Country (2027-2032) Table 245. Middle East and Africa Oral Anti-HBV Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 246. Middle East and Africa Oral Anti-HBV Drugs Sales by Country (2021-2026) & (K Units) Table 247. Middle East and Africa Oral Anti-HBV Drugs Sales Market Share by Country (2021-2026) Table 248. Middle East and Africa Oral Anti-HBV Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 249. Middle East and Africa Oral Anti-HBV Drugs Sales Market Share Forecast by Country (2027-2032) Table 250. Middle East and Africa Oral Anti-HBV Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 251. Middle East and Africa Oral Anti-HBV Drugs Market Size by Country (2021-2026) & (US$ Million) Table 252. Middle East and Africa Oral Anti-HBV Drugs Market Share by Country (2021-2026) Table 253. Middle East and Africa Oral Anti-HBV Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 254. Middle East and Africa Oral Anti-HBV Drugs Market Share Forecast by Country (2027-2032) Table 255. Key Raw Materials Table 256. Raw Materials Key Suppliers Table 257. Oral Anti-HBV Drugs Distributors List Table 258. Oral Anti-HBV Drugs Customers List Table 259. Research Programs/Design for This Report Table 260. Authors List of This Report Table 261. Secondary Sources Table 262. Primary Sources List of Figures Figure 1. Oral Anti-HBV Drugs Image Figure 2. Global Oral Anti-HBV Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Oral Anti-HBV Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Oral Anti-HBV Drugs Sales (2021-2032) & (K Units) Figure 5. Adefovir Image Figure 6. Global Adefovir Sales YoY Growth (2021-2032) & (K Units) Figure 7. Entecavir Image Figure 8. Global Entecavir Sales YoY Growth (2021-2032) & (K Units) Figure 9. Lamivudine Image Figure 10. Global Lamivudine Sales YoY Growth (2021-2032) & (K Units) Figure 11. Telbivudine Image Figure 12. Global Telbivudine Sales YoY Growth (2021-2032) & (K Units) Figure 13. Tenofovir Image Figure 14. Global Tenofovir Sales YoY Growth (2021-2032) & (K Units) Figure 15. Other Image Figure 16. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 17. Global Oral Anti-HBV Drugs Market Size Overview by Type (2021-2032) & (US$ Million) Figure 18. Global Oral Anti-HBV Drugs Market Share by Type 2025 VS 2032 Figure 19. North America Oral Anti-HBV Drugs Sales Market Share in Volume by Type in 2025 Figure 20. North America Oral Anti-HBV Drugs Sales Market Share in Value by Type in 2025 Figure 21. Europe Oral Anti-HBV Drugs Sales Market Share in Volume by Type in 2025 Figure 22. Europe Oral Anti-HBV Drugs Sales Market Share in Value by Type in 2025 Figure 23. Asia-Pacific Oral Anti-HBV Drugs Sales Market Share in Volume by Type in 2025 Figure 24. Asia-Pacific Oral Anti-HBV Drugs Sales Market Share in Value by Type in 2025 Figure 25. Latin America Oral Anti-HBV Drugs Sales Market Share in Volume by Type in 2025 Figure 26. Latin America Oral Anti-HBV Drugs Sales Market Share in Value by Type in 2025 Figure 27. Middle East and Africa Oral Anti-HBV Drugs Sales Market Share in Volume by Type in 2025 Figure 28. Middle East and Africa Oral Anti-HBV Drugs Sales Market Share in Value by Type in 2025 Figure 29. Global Top 5 and 10 Oral Anti-HBV Drugs Players Market Share by Revenue in 2025 Figure 30. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 31. Hospital and Clinic Image Figure 32. Global Hospital and Clinic Sales YoY Growth (2021-2032) & (K Units) Figure 33. Pharmacy Image Figure 34. Global Pharmacy Sales YoY Growth (2021-2032) & (K Units) Figure 35. Other Image Figure 36. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 37. Global Oral Anti-HBV Drugs Market Size Overview by Application (2021-2032) & (US$ Million) Figure 38. Global Oral Anti-HBV Drugs Market Share by Application 2025 VS 2032 Figure 39. North America Oral Anti-HBV Drugs Sales Market Share in Volume by Application in 2025 Figure 40. North America Oral Anti-HBV Drugs Sales Market Share in Value by Application in 2025 Figure 41. Europe Oral Anti-HBV Drugs Sales Market Share in Volume by Application in 2025 Figure 42. Europe Oral Anti-HBV Drugs Sales Market Share in Value by Application in 2025 Figure 43. Asia-Pacific Oral Anti-HBV Drugs Sales Market Share in Volume by Application in 2025 Figure 44. Asia-Pacific Oral Anti-HBV Drugs Sales Market Share in Value by Application in 2025 Figure 45. Latin America Oral Anti-HBV Drugs Sales Market Share in Volume by Application in 2025 Figure 46. Latin America Oral Anti-HBV Drugs Sales Market Share in Value by Application in 2025 Figure 47. Middle East and Africa Oral Anti-HBV Drugs Sales Market Share in Volume by Application in 2025 Figure 48. Middle East and Africa Oral Anti-HBV Drugs Sales Market Share in Value by Application in 2025 Figure 49. North America Oral Anti-HBV Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. North America Oral Anti-HBV Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. North America Oral Anti-HBV Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. North America Oral Anti-HBV Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Oral Anti-HBV Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Europe Oral Anti-HBV Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Europe Oral Anti-HBV Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Europe Oral Anti-HBV Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Oral Anti-HBV Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Asia-Pacific Oral Anti-HBV Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Asia-Pacific Oral Anti-HBV Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Asia-Pacific Oral Anti-HBV Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Oral Anti-HBV Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 62. Latin America Oral Anti-HBV Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Latin America Oral Anti-HBV Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Latin America Oral Anti-HBV Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Oral Anti-HBV Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 66. Middle East and Africa Oral Anti-HBV Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 67. Middle East and Africa Oral Anti-HBV Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 68. Middle East and Africa Oral Anti-HBV Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 69. Oral Anti-HBV Drugs Value Chain Figure 70. Key Raw Materials Price Figure 71. Manufacturing Cost Structure Figure 72. Oral Anti-HBV Drugs Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • Adefovir
  • Entecavir
  • Lamivudine
  • Telbivudine
  • Tenofovir
  • Other
Applications
  • Hospital and Clinic
  • Pharmacy
  • Other
Companies covered
  • Zhongfu Pharmaceutical
  • Chia Tai Tianqing Pharmaceutical
  • Easton Biopharmaceuticals
  • YaoPharma
  • Tianjin Yaowu Academe Pharmaceutical Industry
  • Sichuan Kelun Pharmaceutical
  • Shanghai Desano Pharmaceutical
  • Qianjin Pharmaceutical
  • Qilu Pharmaceutical
  • Jiangxi Qingfeng Pharmaceutical
  • Fujian Cosunter pharmaceutical
  • Chengdu Brilliant Pharmaceutical
  • Cisen Pharmaceutical
  • Beijing SL Pharmaceutical
  • Beijing Baiao Pharmaceutical
  • Anhui Biochem
  • Viatris
  • Towa Pharmaceutical
  • Teva
  • Sigmapharm Laboratories
  • Sandoz Pharmaceuticals
  • GSK
  • Gilead Sciences
  • Camber Pharmaceuticals
  • Bristol Myers Squibb
  • Apotex

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Oral Anti-HBV Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Oral Anti-HBV Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Oral Anti-HBV Drugs Market by Type
  6. 1.3.1 Adefovir
  7. 1.3.2 Entecavir
  8. 1.3.3 Lamivudine
  9. 1.3.4 Telbivudine
  10. 1.3.5 Tenofovir
  11. 1.3.6 Other
  12. 1.4 Global Oral Anti-HBV Drugs Market Size by Type
  13. 1.4.1 Global Oral Anti-HBV Drugs Market Size Overview by Type (2021-2032)
  14. 1.4.2 Global Oral Anti-HBV Drugs Historic Market Size Review by Type (2021-2026)
  15. 1.4.3 Global Oral Anti-HBV Drugs Forecasted Market Size by Type (2027-2032)
  16. 1.5 Key Regions Market Size by Type
  17. 1.5.1 North America Oral Anti-HBV Drugs Sales Breakdown by Type (2021-2026)
  18. 1.5.2 Europe Oral Anti-HBV Drugs Sales Breakdown by Type (2021-2026)
  19. 1.5.3 Asia-Pacific Oral Anti-HBV Drugs Sales Breakdown by Type (2021-2026)
  20. 1.5.4 South America Oral Anti-HBV Drugs Sales Breakdown by Type (2021-2026)
  21. 1.5.5 Middle East and Africa Oral Anti-HBV Drugs Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Oral Anti-HBV Drugs Industry Trends
  2. 2.2 Oral Anti-HBV Drugs Industry Drivers
  3. 2.3 Oral Anti-HBV Drugs Industry Opportunities and Challenges
  4. 2.4 Oral Anti-HBV Drugs Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Oral Anti-HBV Drugs Revenue (2021-2026)
  2. 3.2 Global Top Players by Oral Anti-HBV Drugs Sales (2021-2026)
  3. 3.3 Global Top Players by Oral Anti-HBV Drugs Price (2021-2026)
  4. 3.4 Global Oral Anti-HBV Drugs Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Oral Anti-HBV Drugs Major Company Production Sites & Headquarters
  6. 3.6 Global Oral Anti-HBV Drugs Company, Product Type & Application
  7. 3.7 Global Oral Anti-HBV Drugs Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Oral Anti-HBV Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Oral Anti-HBV Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Oral Anti-HBV Drugs Tier 1, Tier 2, and Tier 3
4 Oral Anti-HBV Drugs Regional Status and Outlook
  1. 4.1 Global Oral Anti-HBV Drugs Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Oral Anti-HBV Drugs Historic Market Size by Region
  3. 4.2.1 Global Oral Anti-HBV Drugs Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Oral Anti-HBV Drugs Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Oral Anti-HBV Drugs Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Oral Anti-HBV Drugs Forecasted Market Size by Region
  7. 4.3.1 Global Oral Anti-HBV Drugs Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Oral Anti-HBV Drugs Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Oral Anti-HBV Drugs Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Oral Anti-HBV Drugs by Application
  1. 5.1 Oral Anti-HBV Drugs Market by Application
  2. 5.1.1 Hospital and Clinic
  3. 5.1.2 Pharmacy
  4. 5.1.3 Other
  5. 5.2 Global Oral Anti-HBV Drugs Market Size by Application
  6. 5.2.1 Global Oral Anti-HBV Drugs Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Oral Anti-HBV Drugs Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Oral Anti-HBV Drugs Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Oral Anti-HBV Drugs Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Oral Anti-HBV Drugs Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Oral Anti-HBV Drugs Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Oral Anti-HBV Drugs Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Oral Anti-HBV Drugs Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Zhongfu Pharmaceutical
  2. 6.1.1 Zhongfu Pharmaceutical Company Information
  3. 6.1.2 Zhongfu Pharmaceutical Business Overview
  4. 6.1.3 Zhongfu Pharmaceutical Oral Anti-HBV Drugs Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Zhongfu Pharmaceutical Oral Anti-HBV Drugs Product Portfolio
  6. 6.1.5 Zhongfu Pharmaceutical Recent Developments
  7. 6.2 Chia Tai Tianqing Pharmaceutical
  8. 6.2.1 Chia Tai Tianqing Pharmaceutical Company Information
  9. 6.2.2 Chia Tai Tianqing Pharmaceutical Business Overview
  10. 6.2.3 Chia Tai Tianqing Pharmaceutical Oral Anti-HBV Drugs Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Chia Tai Tianqing Pharmaceutical Oral Anti-HBV Drugs Product Portfolio
  12. 6.2.5 Chia Tai Tianqing Pharmaceutical Recent Developments
  13. 6.3 Easton Biopharmaceuticals
  14. 6.3.1 Easton Biopharmaceuticals Company Information
  15. 6.3.2 Easton Biopharmaceuticals Business Overview
  16. 6.3.3 Easton Biopharmaceuticals Oral Anti-HBV Drugs Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Easton Biopharmaceuticals Oral Anti-HBV Drugs Product Portfolio
  18. 6.3.5 Easton Biopharmaceuticals Recent Developments
  19. 6.4 YaoPharma
  20. 6.4.1 YaoPharma Company Information
  21. 6.4.2 YaoPharma Business Overview
  22. 6.4.3 YaoPharma Oral Anti-HBV Drugs Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 YaoPharma Oral Anti-HBV Drugs Product Portfolio
  24. 6.4.5 YaoPharma Recent Developments
  25. 6.5 Tianjin Yaowu Academe Pharmaceutical Industry
  26. 6.5.1 Tianjin Yaowu Academe Pharmaceutical Industry Company Information
  27. 6.5.2 Tianjin Yaowu Academe Pharmaceutical Industry Business Overview
  28. 6.5.3 Tianjin Yaowu Academe Pharmaceutical Industry Oral Anti-HBV Drugs Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Tianjin Yaowu Academe Pharmaceutical Industry Oral Anti-HBV Drugs Product Portfolio
  30. 6.5.5 Tianjin Yaowu Academe Pharmaceutical Industry Recent Developments
  31. 6.6 Sichuan Kelun Pharmaceutical
  32. 6.6.1 Sichuan Kelun Pharmaceutical Company Information
  33. 6.6.2 Sichuan Kelun Pharmaceutical Business Overview
  34. 6.6.3 Sichuan Kelun Pharmaceutical Oral Anti-HBV Drugs Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Sichuan Kelun Pharmaceutical Oral Anti-HBV Drugs Product Portfolio
  36. 6.6.5 Sichuan Kelun Pharmaceutical Recent Developments
  37. 6.7 Shanghai Desano Pharmaceutical
  38. 6.7.1 Shanghai Desano Pharmaceutical Company Information
  39. 6.7.2 Shanghai Desano Pharmaceutical Business Overview
  40. 6.7.3 Shanghai Desano Pharmaceutical Oral Anti-HBV Drugs Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Shanghai Desano Pharmaceutical Oral Anti-HBV Drugs Product Portfolio
  42. 6.7.5 Shanghai Desano Pharmaceutical Recent Developments
  43. 6.8 Qianjin Pharmaceutical
  44. 6.8.1 Qianjin Pharmaceutical Company Information
  45. 6.8.2 Qianjin Pharmaceutical Business Overview
  46. 6.8.3 Qianjin Pharmaceutical Oral Anti-HBV Drugs Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Qianjin Pharmaceutical Oral Anti-HBV Drugs Product Portfolio
  48. 6.8.5 Qianjin Pharmaceutical Recent Developments
  49. 6.9 Qilu Pharmaceutical
  50. 6.9.1 Qilu Pharmaceutical Company Information
  51. 6.9.2 Qilu Pharmaceutical Business Overview
  52. 6.9.3 Qilu Pharmaceutical Oral Anti-HBV Drugs Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Qilu Pharmaceutical Oral Anti-HBV Drugs Product Portfolio
  54. 6.9.5 Qilu Pharmaceutical Recent Developments
  55. 6.10 Jiangxi Qingfeng Pharmaceutical
  56. 6.10.1 Jiangxi Qingfeng Pharmaceutical Company Information
  57. 6.10.2 Jiangxi Qingfeng Pharmaceutical Business Overview
  58. 6.10.3 Jiangxi Qingfeng Pharmaceutical Oral Anti-HBV Drugs Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Jiangxi Qingfeng Pharmaceutical Oral Anti-HBV Drugs Product Portfolio
  60. 6.10.5 Jiangxi Qingfeng Pharmaceutical Recent Developments
  61. 6.11 Fujian Cosunter pharmaceutical
  62. 6.11.1 Fujian Cosunter pharmaceutical Company Information
  63. 6.11.2 Fujian Cosunter pharmaceutical Business Overview
  64. 6.11.3 Fujian Cosunter pharmaceutical Oral Anti-HBV Drugs Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Fujian Cosunter pharmaceutical Oral Anti-HBV Drugs Product Portfolio
  66. 6.11.5 Fujian Cosunter pharmaceutical Recent Developments
  67. 6.12 Chengdu Brilliant Pharmaceutical
  68. 6.12.1 Chengdu Brilliant Pharmaceutical Company Information
  69. 6.12.2 Chengdu Brilliant Pharmaceutical Business Overview
  70. 6.12.3 Chengdu Brilliant Pharmaceutical Oral Anti-HBV Drugs Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Chengdu Brilliant Pharmaceutical Oral Anti-HBV Drugs Product Portfolio
  72. 6.12.5 Chengdu Brilliant Pharmaceutical Recent Developments
  73. 6.13 Cisen Pharmaceutical
  74. 6.13.1 Cisen Pharmaceutical Company Information
  75. 6.13.2 Cisen Pharmaceutical Business Overview
  76. 6.13.3 Cisen Pharmaceutical Oral Anti-HBV Drugs Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Cisen Pharmaceutical Oral Anti-HBV Drugs Product Portfolio
  78. 6.13.5 Cisen Pharmaceutical Recent Developments
  79. 6.14 Beijing SL Pharmaceutical
  80. 6.14.1 Beijing SL Pharmaceutical Company Information
  81. 6.14.2 Beijing SL Pharmaceutical Business Overview
  82. 6.14.3 Beijing SL Pharmaceutical Oral Anti-HBV Drugs Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Beijing SL Pharmaceutical Oral Anti-HBV Drugs Product Portfolio
  84. 6.14.5 Beijing SL Pharmaceutical Recent Developments
  85. 6.15 Beijing Baiao Pharmaceutical
  86. 6.15.1 Beijing Baiao Pharmaceutical Company Information
  87. 6.15.2 Beijing Baiao Pharmaceutical Business Overview
  88. 6.15.3 Beijing Baiao Pharmaceutical Oral Anti-HBV Drugs Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Beijing Baiao Pharmaceutical Oral Anti-HBV Drugs Product Portfolio
  90. 6.15.5 Beijing Baiao Pharmaceutical Recent Developments
  91. 6.16 Anhui Biochem
  92. 6.16.1 Anhui Biochem Company Information
  93. 6.16.2 Anhui Biochem Business Overview
  94. 6.16.3 Anhui Biochem Oral Anti-HBV Drugs Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 Anhui Biochem Oral Anti-HBV Drugs Product Portfolio
  96. 6.16.5 Anhui Biochem Recent Developments
  97. 6.17 Viatris
  98. 6.17.1 Viatris Company Information
  99. 6.17.2 Viatris Business Overview
  100. 6.17.3 Viatris Oral Anti-HBV Drugs Sales, Revenue and Gross Margin (2021-2026)
  101. 6.17.4 Viatris Oral Anti-HBV Drugs Product Portfolio
  102. 6.17.5 Viatris Recent Developments
  103. 6.18 Towa Pharmaceutical
  104. 6.18.1 Towa Pharmaceutical Company Information
  105. 6.18.2 Towa Pharmaceutical Business Overview
  106. 6.18.3 Towa Pharmaceutical Oral Anti-HBV Drugs Sales, Revenue and Gross Margin (2021-2026)
  107. 6.18.4 Towa Pharmaceutical Oral Anti-HBV Drugs Product Portfolio
  108. 6.18.5 Towa Pharmaceutical Recent Developments
  109. 6.19 Teva
  110. 6.19.1 Teva Company Information
  111. 6.19.2 Teva Business Overview
  112. 6.19.3 Teva Oral Anti-HBV Drugs Sales, Revenue and Gross Margin (2021-2026)
  113. 6.19.4 Teva Oral Anti-HBV Drugs Product Portfolio
  114. 6.19.5 Teva Recent Developments
  115. 6.20 Sigmapharm Laboratories
  116. 6.20.1 Sigmapharm Laboratories Company Information
  117. 6.20.2 Sigmapharm Laboratories Business Overview
  118. 6.20.3 Sigmapharm Laboratories Oral Anti-HBV Drugs Sales, Revenue and Gross Margin (2021-2026)
  119. 6.20.4 Sigmapharm Laboratories Oral Anti-HBV Drugs Product Portfolio
  120. 6.20.5 Sigmapharm Laboratories Recent Developments
  121. 6.21 Sandoz Pharmaceuticals
  122. 6.21.1 Sandoz Pharmaceuticals Company Information
  123. 6.21.2 Sandoz Pharmaceuticals Business Overview
  124. 6.21.3 Sandoz Pharmaceuticals Oral Anti-HBV Drugs Sales, Revenue and Gross Margin (2021-2026)
  125. 6.21.4 Sandoz Pharmaceuticals Oral Anti-HBV Drugs Product Portfolio
  126. 6.21.5 Sandoz Pharmaceuticals Recent Developments
  127. 6.22 GSK
  128. 6.22.1 GSK Company Information
  129. 6.22.2 GSK Business Overview
  130. 6.22.3 GSK Oral Anti-HBV Drugs Sales, Revenue and Gross Margin (2021-2026)
  131. 6.22.4 GSK Oral Anti-HBV Drugs Product Portfolio
  132. 6.22.5 GSK Recent Developments
  133. 6.23 Gilead Sciences
  134. 6.23.1 Gilead Sciences Company Information
  135. 6.23.2 Gilead Sciences Business Overview
  136. 6.23.3 Gilead Sciences Oral Anti-HBV Drugs Sales, Revenue and Gross Margin (2021-2026)
  137. 6.23.4 Gilead Sciences Oral Anti-HBV Drugs Product Portfolio
  138. 6.23.5 Gilead Sciences Recent Developments
  139. 6.24 Camber Pharmaceuticals
  140. 6.24.1 Camber Pharmaceuticals Company Information
  141. 6.24.2 Camber Pharmaceuticals Business Overview
  142. 6.24.3 Camber Pharmaceuticals Oral Anti-HBV Drugs Sales, Revenue and Gross Margin (2021-2026)
  143. 6.24.4 Camber Pharmaceuticals Oral Anti-HBV Drugs Product Portfolio
  144. 6.24.5 Camber Pharmaceuticals Recent Developments
  145. 6.25 Bristol Myers Squibb
  146. 6.25.1 Bristol Myers Squibb Company Information
  147. 6.25.2 Bristol Myers Squibb Business Overview
  148. 6.25.3 Bristol Myers Squibb Oral Anti-HBV Drugs Sales, Revenue and Gross Margin (2021-2026)
  149. 6.25.4 Bristol Myers Squibb Oral Anti-HBV Drugs Product Portfolio
  150. 6.25.5 Bristol Myers Squibb Recent Developments
  151. 6.26 Apotex
  152. 6.26.1 Apotex Company Information
  153. 6.26.2 Apotex Business Overview
  154. 6.26.3 Apotex Oral Anti-HBV Drugs Sales, Revenue and Gross Margin (2021-2026)
  155. 6.26.4 Apotex Oral Anti-HBV Drugs Product Portfolio
  156. 6.26.5 Apotex Recent Developments
7 North America by Country
  1. 7.1 North America Oral Anti-HBV Drugs Sales by Country
  2. 7.1.1 North America Oral Anti-HBV Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Oral Anti-HBV Drugs Sales by Country (2021-2026)
  4. 7.1.3 North America Oral Anti-HBV Drugs Sales Forecast by Country (2027-2032)
  5. 7.2 North America Oral Anti-HBV Drugs Market Size by Country
  6. 7.2.1 North America Oral Anti-HBV Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Oral Anti-HBV Drugs Market Size by Country (2021-2026)
  8. 7.2.3 North America Oral Anti-HBV Drugs Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Oral Anti-HBV Drugs Sales by Country
  2. 8.1.1 Europe Oral Anti-HBV Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Oral Anti-HBV Drugs Sales by Country (2021-2026)
  4. 8.1.3 Europe Oral Anti-HBV Drugs Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Oral Anti-HBV Drugs Market Size by Country
  6. 8.2.1 Europe Oral Anti-HBV Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Oral Anti-HBV Drugs Market Size by Country (2021-2026)
  8. 8.2.3 Europe Oral Anti-HBV Drugs Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Oral Anti-HBV Drugs Sales by Country
  2. 9.1.1 Asia-Pacific Oral Anti-HBV Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Oral Anti-HBV Drugs Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Oral Anti-HBV Drugs Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Oral Anti-HBV Drugs Market Size by Country
  6. 9.2.1 Asia-Pacific Oral Anti-HBV Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Oral Anti-HBV Drugs Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Oral Anti-HBV Drugs Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Oral Anti-HBV Drugs Sales by Country
  2. 10.1.1 South America Oral Anti-HBV Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Oral Anti-HBV Drugs Sales by Country (2021-2026)
  4. 10.1.3 South America Oral Anti-HBV Drugs Sales Forecast by Country (2027-2032)
  5. 10.2 South America Oral Anti-HBV Drugs Market Size by Country
  6. 10.2.1 South America Oral Anti-HBV Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Oral Anti-HBV Drugs Market Size by Country (2021-2026)
  8. 10.2.3 South America Oral Anti-HBV Drugs Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Oral Anti-HBV Drugs Sales by Country
  2. 11.1.1 Middle East and Africa Oral Anti-HBV Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Oral Anti-HBV Drugs Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Oral Anti-HBV Drugs Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Oral Anti-HBV Drugs Market Size by Country
  6. 11.2.1 Middle East and Africa Oral Anti-HBV Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Oral Anti-HBV Drugs Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Oral Anti-HBV Drugs Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Oral Anti-HBV Drugs Value Chain Analysis
  2. 12.1.1 Oral Anti-HBV Drugs Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Oral Anti-HBV Drugs Production Mode & Process
  7. 12.2 Oral Anti-HBV Drugs Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Oral Anti-HBV Drugs Distributors
  10. 12.2.3 Oral Anti-HBV Drugs Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst